The introduction of new agents immunomodulatory drugs (IMiDs) and proteasome inhibitors has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and refractory ...

For patients with chronic hepatitis B virus (HBV) infection with virologic suppression with nucleoside or nucleotide a ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Chronic Venous Ulceration ...

STOCKHOLM, Dec. 13, 2024 /PRNewswire/ -- Diamyd Medical today announced a positive in-person Type C meeting with the U.S. Food and Drug Administration (FDA), where alignment was achieved on key ...

There are two cell therapies approved in this patient setting, Johnson & Johnson’s Carvykti and Bristol Myers Squibb's Abecma ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...

Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children's Hospital ...

These cells have demonstrated multiple beneficial effects, including anti-inflammatory, immunomodulatory and protective mechanisms for the developing brain. Looking Ahead The success of this ...

MACAU SAR - Media OutReach Newswire - 12 December 2024 - The University of Macau (UM) has made significant progress in ...

A significant overall survival (OS) benefit with belantamab mafodotin (belantamab; Blenrep) in a phase III trial of relapsed ...

With that, we might be able to sort of identify immunogenic subgroups that may benefit more from immunomodulatory strategies, ...

H.C. Wainwright analyst Matthew Keller initiated coverage of GRI Bio (GRI) with a Buy rating and $10 price target GRI is a clinical stage ...